<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
Louise Fordham

Louise Fordham

Louise Fordham is Editor at Biotech and Money
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Posts by Louise Fordham

Infographic: C-suite challenges in life sciences 2...

In early 2017, LSX, formerly Biotech and Money, published the inaugural Inv...

Read More

CMR Surgical prepares for commercialisation on the...

Key findings: In June 2018, surgical robotics company CMR Surgical raised $...

Read More

Endomag secures £8m Series C for scale up

Key learnings: UK and US-based Endomag raised £8 million through its Series...

Read More

Investorview: Ingredients for growth in life scien...

Industrifonden is an evergreen venture capital fund with headquarters in St...

Read More

PharmaKrysto kickstarts cystinuria drug developmen...

Key learnings: PharmaKrysto has signed a licensing deal with Rutgers Univer...

Read More

Appleyard Lees: Applying in-house expertise to dev...

Key learnings: UK-based Appleyard Lees provides clients worldwide with a fu...

Read More

Inceptua: Partnering with life sciences companies ...

Key learnings: Inceptua Group’s expanded breadth of capabilities across cli...

Read More

Avacta looks to deals to leverage Affimer platform...

Key learnings: UK-based Avacta Group has developed Affimer® technology, an ...

Read More

Unlocking Potential in the Nordic Life Sciences Se...

In 2017, life science companies in Scandinavia raised almost $2.2 billion t...

Read More

Investorview: Why people are key in life science i...

Since it was founded in 1996, European venture capital firm HealthCap has i...

Read More

Investorview: Plugging knowledge gaps to accelerat...

Venture capital firm Hadean Ventures closed its first fund at the end of 20...

Read More

Novoheart expands global presence to support comme...

Key learnings: Novoheart has developed human bioengineered heart constructs...

Read More

Add Your Response